Literature DB >> 23588627

Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation.

Konstantinos A Gatzoulis1, Apostolos-Ilias Vouliotis, Dimitris Tsiachris, Maria Salourou, Stefanos Archontakis, Polychronis Dilaveris, Theodoros Gialernios, Petros Arsenos, Georgios Karystinos, Skevos Sideris, Ioannis Kallikazaros, Christodoulos Stefanadis.   

Abstract

BACKGROUND: We considered the role of programmed ventricular stimulation in primary prevention of sudden cardiac death in an idiopathic dilated cardiomyopathy population. METHODS AND
RESULTS: One hundred fifty-eight patients with idiopathic dilated cardiomyopathy underwent programmed ventricular stimulation. Ventricular tachycardia/ventricular fibrillation was triggered in 44 patients (group I, 27.8%) versus 114 patients (group II), where ventricular tachycardia/ventricular fibrillation was not induced. Sixty-nine patients with idiopathic dilated cardiomyopathy underwent implantable cardioverter-defibrillator (ICD) implantation: 41/44 in group I and 28/114 in group II. The major end points of the study were overall mortality and appropriate ICD activation. Overall mortality during the 46.9 months of mean follow-up was not significantly different between the 2 groups. Patients with left ventricular ejection fraction ≤35% (n=119) demonstrated a higher overall mortality rate compared with the patients with left ventricular ejection fraction >35% (n=39; 16.8% versus 10.3%, log-rank P=0.025). Advanced New York Heart Association class (III and IV versus I and II) was the single independent and strongest prognostic factor of overall mortality (hazard ratio, 11.909; P<0.001; confidence interval, 3.106-45.65), as well as of cardiac mortality (hazard ratio, 14.787; P=0.001; confidence interval, 2.958-73.922). Among ICD recipients, ICD activation rate was significantly higher in group I compared with group II (30 of 41 patients-73.2% versus 5 of 28 patients-17.9%; log-rank P=0.001), either in the form of antitachycardia pacing (68.3% versus 17.9%; log-rank P=0.001) or in the shock delivery form (51.2% versus 17.9%; log-rank P=0.05). Induction of ventricular tachycardia/ventricular fibrillation during programmed ventricular stimulation in contrast to left ventricular ejection fraction was the single independent prognostic factor for future ICD activation (hazard ratio, 4.195; P=0.007; confidence interval, 1.467-11.994).
CONCLUSIONS: Inducibility of ventricular tachycardia/ventricular fibrillation was associated with an increased likelihood of subsequent ICD activation and sudden cardiac death surrogate.

Entities:  

Keywords:  dilated cardiomyopathy; electrophysiology test; implantable cardioverter-defibrillator; primary prevention; risk stratification

Mesh:

Year:  2013        PMID: 23588627     DOI: 10.1161/CIRCEP.113.000216

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  19 in total

1.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Saenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  J Interv Card Electrophysiol       Date:  2020-10       Impact factor: 1.900

2.  Multiple autonomic and repolarization investigation of sudden cardiac death in dilated cardiomyopathy and controls.

Authors:  Thomas Pezawas; André Diedrich; Robert Winker; David Robertson; Bernhard Richter; Li Wang; Daniel W Byrne; Herwig Schmidinger
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-09-27

Review 3.  Arrhythmic risk stratification in heart failure: Time for the next step?

Authors:  Konstantinos A Gatzoulis; Antonios Sideris; Emmanuel Kanoupakis; Skevos Sideris; Nikolaos Nikolaou; Christos-Konstantinos Antoniou; Theofilos M Kolettis
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-02-03       Impact factor: 1.468

4.  Utility of electrophysiological studies to predict arrhythmic events.

Authors:  Gabriela Hilfiker; Andreas W Schoenenberger; Paul Erne; Richard Kobza
Journal:  World J Cardiol       Date:  2015-06-26

5.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Sáenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  Europace       Date:  2019-08-01       Impact factor: 5.214

6.  [Risk stratification of sudden cardiac death in dilated cardiomyopathy. Programmed ventricular stimulation].

Authors:  Dietmar Bänsch
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2015-02-19

7.  Predictors of serious arrhythmic events in patients with nonischemic heart failure.

Authors:  Mauricio Pimentel; André Zimerman; Diego Chemello; Vanessa Giaretta; Michael Andrades; Daiane Silvello; Leandro Zimerman; Luis E Rohde
Journal:  J Interv Card Electrophysiol       Date:  2016-12-10       Impact factor: 1.900

8.  Deceleration Capacity of Heart Rate Predicts Arrhythmic and Total Mortality in Heart Failure Patients.

Authors:  Petros Arsenos; George Manis; Konstantinos A Gatzoulis; Polychronis Dilaveris; Theodoros Gialernios; Athanasios Angelis; Achileas Papadopoulos; Erifili Venieri; Athanasios Trikas; Dimitris Tousoulis
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-04-01       Impact factor: 1.468

9.  Electrophysiologic testing guided risk stratification approach for sudden cardiac death beyond the left ventricular ejection fraction.

Authors:  Konstantinos A Gatzoulis; Dimitris Tsiachris; Petros Arsenos; Dimitris Tousoulis
Journal:  World J Cardiol       Date:  2016-01-26

Review 10.  Beyond Ejection Fraction: Novel Clinical Approaches Towards Sudden Cardiac Death Risk Stratification in Patients with Dilated Cardiomyopathy.

Authors:  Issa Pour-Ghaz; Mark Heckle; Ikechukwu Ifedili; Sharif Kayali; Christopher Nance; Rajesh Kabra; Sunil K Jha; John L Jefferies; Yehoshua C Levine
Journal:  Curr Cardiol Rev       Date:  2022
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.